🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseLiver biopsy changes on semaglutide — November 2025 Page 5

Liver biopsy changes on semaglutide — November 2025

hank_denver Fri, Apr 17, 2026 at 2:54 AM 23 replies 1,081 viewsPage 5 of 5
marco_milano
Member
345
1,456
Jul 2024
Milan, IT
May 4, 2026 at 9:00 AM#21
Dr.RaviCardio said:
The dose-response is real but shallow at the top.

Agreed, and ALT falling is not the same as fibrosis improving. Enzymes are a crude proxy; FIB-4 or elastography is what tells you about the thing that matters.

Ask again with the specifics and you will get a better answer than this one.

34 7kevin_tulsa, Dr.PainCLE, mike_mealprep and 31 others
Reply Quote Save Share Report
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
May 9, 2026 at 3:39 PM#22
Dr.RaviCardio said:
The dose-response is real but shallow at the top.

Thank you for spelling out the reasoning rather than just the conclusion. Adding it to my notes with a link back to this thread.

Last edited: May 9, 2026 at 4:39 PM
35 8PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 32 others
Reply Quote Save Share Report
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
May 14, 2026 at 10:21 PM#23

Adding the clinical framing, because it changes how the question reads. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

That is the short version; the long version is somebody else's post.

36 9JennaRN, LabKate, kate.chem and 33 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
ricardo_MIA
Member
378
1,678
Sep 2024
Miami, FL
May 20, 2026 at 5:06 AM#24
MASHdoc_SA said:
It is worth asking what the claim would look like if it were false.

Adding a me-too, because a thread of one person's experience is not much use. The detail I would add is minor and it is already implied above.

Last edited: May 20, 2026 at 10:06 AM
37 10KetoKyle, CanadaChris, ZaraB_AL and 34 others
Reply Quote Save Share Report
AttorneyGrant
Member
567
2,890
Apr 2024
Washington, DC
May 25, 2026 at 11:54 AM#25
MASHdoc_SA said:
It is worth asking what the claim would look like if it were false.

Adding the part of the answer the thread has not reached. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

38 11Dr.GastroMayo, JakeBK_lifts, DerekSJ_a1c and 35 others
Reply Quote Save Share Report
1345

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register